Updated:
Global Health Impact Funds
Global Health Impact Funds was founded in 2018 and is headquartered in Walnut Creek, California.
Global Health Impact Funds
Global Health Impact Funds was founded in 2018 and is headquartered in Walnut Creek, California. The firm operates as an early-stage venture capital manager targeting healthcare technology companies across the United States. Its formation coincides with a period of rapid digitization in clinical workflows, diagnostics, and patient engagement, though the principals and specific wealth-origin story behind the firm remain absent from public record. The firm deploys capital at the seed and start-up stages, concentrating exclusively on healthcare technology. It looks for companies where software, data, or device innovation can create clinical or operational efficiency gains. While specific portfolio holdings are not publicly disclosed, a name like Global Health Impact Funds suggests a mandate that prioritizes both financial return and health-outcome metrics. The firm likely evaluates opportunities across digital health, telemedicine infrastructure, remote patient monitoring, and health-data interoperability. Its geographic footprint is U.S.-focused, with no disclosed international offices or cross-border investment programs. The scale of the firm is opaque. Total professionals, fund sizes, and cumulative deployment figures are not publicly reported. No adjacent vehicles—such as philanthropic foundations, real-asset arms, or operating businesses—appear in available records. The firm maintains a minimal digital presence, with its domain (globalhealthimpactfund.com) active but offering no scraped team profiles, strategy documents, or portfolio announcements as of the most recent crawl. The structural differentiator for Global Health Impact Funds is its explicit health-impact mandate paired with a generalist VC structure. Unlike a corporate venture arm tied to a single health system or a mission-related investment program within a foundation, it operates as a standalone asset manager. This architecture allows it to raise discretionary capital from limited partners who want exposure to healthcare innovation without being embedded inside a single delivery network. How the firm measures and reports impact—or whether it uses a double-bottom-line framework—remains unconfirmed and is a key diligence item for prospective allocators.
General information
Firm type
Private Equity
Year founded
2018
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Walnut Creek
Corporate office
Walnut Creek, CA, United States
Sector focus
Frequently asked questions
What stage does Global Health Impact Funds target?
The firm invests at the earliest phases of a company's life—specifically seed and start-up rounds. This positioning means it often writes first or second institutional checks into healthcare technology companies before they have meaningful commercial traction. For allocators, the return profile is likely binary and dependent on a small number of home runs, consistent with the broader early-stage venture asset class.
Does the firm invest exclusively in U.S. companies?
Available data indicates a U.S.-only investment footprint. No international offices, cross-border deal activity, or non-U.S. portfolio companies have been disclosed. Allocators seeking developed-market healthcare exposure without emerging-market governance risk may find this focus appropriate, though direct confirmation from the manager is necessary.
Who runs investment decisions at Global Health Impact Funds?
The principals and investment committee members are not identified in public record. The firm's minimal web presence and absence from LinkedIn mean that operational leadership, prior track record, and decision-making structure cannot be independently verified. This is a critical diligence gap for any allocator considering a commitment.
How does Global Health Impact Funds measure impact?
The firm's name signals an intent to link financial returns with health outcomes, but it does not publicly share an impact framework, theory of change, or set of key performance indicators. It is unclear whether the firm uses a formal impact-measurement system such as IRIS+ or tracks outputs like patient lives improved, cost reductions, or clinical workflow gains. Allocators with impact mandates should request a detailed impact report.
Is Global Health Impact Funds a single-family office or a traditional venture fund?
It is structured as a traditional asset manager, not a family office. The firm raises capital from external limited partners and operates as a private equity manager. There is no known connection to a single-family wealth pool, foundation, or health system, which distinguishes it from internally capitalized impact investors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: